The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.
about
Role of insulin in the type 2 diabetes therapy: past, present and futureThe metabolic and mitogenic properties of basal insulin analoguesImpact of glucose-lowering agents on the risk of cancer in type 2 diabetic patients. The Barcelona case-control studyCancer biology in diabetes.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Use of insulin and insulin analogs and risk of cancer - systematic review and meta-analysis of observational studies.Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.Associations between diabetes medication use and risk of second breast cancer events and mortalityClinical benefits of metformin in gynecologic oncology.Treatment with insulin (analogues) and breast cancer risk in diabetics; a systematic review and meta-analysis of in vitro, animal and human evidence.Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering.Design of non-standard insulin analogs for the treatment of diabetes mellitusInsulin therapy and cancer in type 2 diabetes.Does insulin glargine increase the risk of cancer compared with other basal insulins?: A French nationwide cohort study based on national administrative databases.Cancer incidence among those initiating insulin therapy with glargine versus human NPH insulin.Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes.Insulin therapy and cancer.Sex and gender influences on pharmacological response: an overview.Continuous use of metformin can improve survival in type 2 diabetic patients with ovarian cancer: A retrospective study.
P2860
Q22241148-22A16D24-426F-4D53-82FF-D509E58C4DA4Q26991486-171C2A76-82DA-4BD0-ACEE-18039C42EAB5Q28535372-4749E8BE-1288-4204-BAE4-98FDBD531B28Q33608038-52B5825B-DDF8-4BB9-B1BB-1DDD44873930Q34069086-610E182E-C705-4334-958C-70F0080AC677Q35038355-C1FEC63F-32A2-4056-A54B-55E23C994A92Q35832508-A84E3B3E-BE2E-43E0-9581-05EC95809237Q35850213-19A4A4B6-2022-43E0-A946-56834F8562A0Q35871269-22B67437-D6AD-418A-AC7A-33FA89CBB842Q35937961-872AB658-C359-485B-B7D2-AF5A7C2BB15EQ35988978-28DD8DC6-CE4C-40D7-AA8A-91B35281BA92Q36374363-F7E220D5-5A00-4E47-AA05-FA9D5502A796Q36417868-E5E58F24-B281-419A-8DFE-7C04D812A362Q36560372-E16F5387-8140-40BF-AFA6-96B9C0775223Q37278227-670BE3D0-A278-4CA8-A37E-E9270770F3CBQ37331188-5D0AA7B4-B13A-4800-9F04-91822E2D9696Q37577175-DEA22D9B-3933-4D7F-90BB-8C8E8F701578Q38214338-BBCCB04E-A948-4DE6-BCAB-E70291B70613Q41091261-533E0219-BF17-46D1-8731-963D4AC924BF
P2860
The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: an observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
The relationship between the e ...... nts in patients with diabetes.
@en
The relationship between the e ...... nts in patients with diabetes.
@nl
type
label
The relationship between the e ...... nts in patients with diabetes.
@en
The relationship between the e ...... nts in patients with diabetes.
@nl
prefLabel
The relationship between the e ...... nts in patients with diabetes.
@en
The relationship between the e ...... nts in patients with diabetes.
@nl
P2093
P1476
The relationship between the e ...... ents in patients with diabetes
@en
P2093
Anders Odén
Marcus Lind
Martin Fahlén
P356
10.1016/J.PCD.2011.10.004
P577
2011-11-04T00:00:00Z